Nailesh Bhatt - 17 May 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Director
Signature
/s/ John Harry Cross III, power of attorney
Issuer symbol
SONN
Transactions as of
17 May 2023
Net transactions value
+$5,800
Form type
4
Filing time
18 May 2023, 08:00:23 UTC
Previous filing
22 Dec 2022
Next filing
05 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Purchase $5,800 +25,000 +436% $0.2320 30,733 17 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes unvested RSUs.